This Swedish Small-Cap Monopoly Is Growing 30%+ and Just Got Cheap for the First Time in Years.
The market thinks the discount is permanent. It isn't. Here's the catch keeping it cheap, the one risk that actually matters, and the catalyst that re-rates it.
Every so often, you find a business that shouldn’t exist.
Not because it’s impossible. Because it’s so good, so cleanly dominant, that you wonder how the rest of the industry let it happen.
This is one of those. A small Scandinavian medical device company that did something almost nobody manages. It didn’t just win a market. It got a regulator to create a brand new product category, then walked in as the only member of it. A monopoly with a government-issued moat around it.
The numbers behind it are the kind that make quality investors lean in. Gross margins of roughly 95%. An adjusted operating margin in the mid-20s and climbing. Sales compounding north of 30% at constant currency. Strong cash generation, a clean balance sheet, and a product that doesn’t just sell well, it saves limbs and, in some studies, lives.
And here’s the part that made me write this.
For the first time in years, the stock trades below its own historical valuation. Not below some peer group. Below are the multiple averages this exact business has averaged for half a decade. The market fell out of love with it, and the price tells the story.
So either the market is right, and something is quietly breaking. Or it’s wrong, and a high-quality compounder went on sale while everyone was distracted by a currency optical illusion.
There’s a real bear case here. There’s a genuine catalyst landing in the next few months that could flip the whole narrative. And there’s a valuation question that, for once, actually tilts in the buyer’s favor.
Let me show you all of it.
🔒The rest of this analysis is for Premium subscribers. Below the line: the company, the moat, the full bull and bear case, the 2026 catalyst calendar, and exactly where the valuation sits today.
A Bloomberg terminal costs $31,980 a year to dig this up yourself.
I’m giving it to you for less than the price of a coffee a day.
→ Join Fluent Few Premium for only €25/month or €275/year
First 14 days on me. No questions asked.
